Nicox Announces Conference Attendance in H1 2026 and Upcoming Scientific Data Presentations
Press Release Nicox Announces Conference Attendance in H1 2026 and Upcoming Scientific…
Valneva Provides Update on Chikungunya Vaccine IXCHIQ
Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of…
![Metabo Drops 2026 [Latest Update]: Is It Legit? Liquid Delivery Science, Ingredient Research, and Informed Consumer Analysis](https://i3.wp.com/fixedagency.com/wp-content/uploads/2026/01/Metabo-Drops-2026-Latest-Update-Is-It-Legit-Liquid-Delivery-Science-Ingredient-Research-and-Informed-Consumer-Analysis.jpg?w=420&resize=420,280&ssl=1 "Metabo Drops 2026 [Latest Update]: Is It Legit? Liquid Delivery Science, Ingredient Research, and Informed Consumer Analysis")
Metabo Drops 2026 [Latest Update]: Is It Legit? Liquid Delivery Science, Ingredient Research, and Informed Consumer Analysis
NEW YORK, NY, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article…
Immuron Reports Continued Sales Growth
Sales Highlights (unaudited): Global H1 sales AUD$4.2 million up 5% on prior…
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for…
Concept Life Sciences Appoints Dr Adam Davenport as CSO to Strengthen Leadership in Integrated Drug Discovery
January 19, 2026 03:00 ET | Source: Concept Life Sciences CHAPEL-EN-LE-FRITH, United…
SEON Launches Identity Verification Built on Real-Time Fraud Intelligence
LONDON and BARCELONA, Spain, Jan. 19, 2026 (GLOBE NEWSWIRE) -- SEON, the…
ASM pre-announces Q4 bookings and revenue ahead of expectations
Almere, The NetherlandsJanuary 19, 2026, 8:00 a.m. CET ASM International N.V. (Euronext…
Riber receives a new order from Japan for MBE 6000 to scale Quantum Dot Laser production for Datacom.
January 19, 2026 02:00 ET | Source: RIBER Riber receives a new…
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 16:05 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Jan.…
